Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedAdds a recruitment status note ('No longer looking for participants') and new help/navigation items ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with an updated revision tag (Revision: v3.6.0). It also removes older topics and sections ('Intervention / Treatment', 'Multiple myeloma', MedlinePlus Genetics, and the prior revision tag Revision: v3.5.5).SummaryDifference0.7%

- Check13 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5, signaling a minor update to the page version without altering trial details.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded related topic entries under the MedlinePlus related topics section. Specifically lists 'Multiple myeloma' and 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, indicating a new revision of the page without changing its visible content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page’s footer shows a site release/version bump from **Revision: v3.5.2** to **Revision: v3.5.3**. Additionally, the “related topics” section content that included “Multiple myeloma” and MedlinePlus Genetics appears to have been removed.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.